Abstract

According to statistics, the number of patients with chronic heart failure (CHF) is growing in Russia. The cause of CHF can be various comorbid conditions that will aggravate the course of CHF. Objective. To determine the clinical features of the course of CHF in the context of COVID-19. Materials and methods. The retrospective study included 210 patients with a confirmed diagnosis of CHF and COVID-19 hospitalized in the pulmonology department. To assess the course of CHF, we used data on the severity of CHF symptoms (severity of shortness of breath on the mMRC scale, chest pain, presence of edema, level of physical activity) and objective examination data (blood pressure level, pulse dynamics). Results and conclusions. The risk group for severe COVID-19 included patients over 60 years of age with concomitant diseases. The clinical picture is noteworthy: severe shortness of breath, significant limitation of physical activity, and swelling in some patients. Patients with CHF during the treatment of COVID-19 require mandatory correction of both the underlying and concomitant diseases to prevent decompensation of CHF and death from all causes.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call